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Mastitomics, the integrated omics of bovine milk
in an experimental model of Streptococcus uberis
mastitis: 3. Untargeted metabolomics†
Funmilola Clara Thomas,‡a Manikhandan Mudaliar,‡ab Riccardo Tassi,c
Tom N. McNeilly,c Richard Burchmore,bd Karl Burgess,bd Pawel Herzyk,be
Ruth N. Zadoksac and P. David Eckersall*a
Intramammary infection leading to bovine mastitis is the leading disease problem affecting dairy cows
and has marked effects on the milk produced by infected udder quarters. An experimental model
of Streptococcus uberis mastitis has previously been investigated for clinical, immunological and
pathophysiological alteration in milk, and has been the subject of peptidomic and quantitative proteomic
investigation. The same sample set has now been investigated with a metabolomics approach using
liquid chromatography and mass spectrometry. The analysis revealed over 3000 chromatographic peaks,
of which 690 were putatively annotated with a metabolite. Hierarchical clustering analysis and principal
component analysis demonstrated that metabolite changes due to S. uberis infection were maximal at
81 hours post challenge with metabolites in the milk from the resolution phase at 312 hours post
challenge being closest to the pre-challenge samples. Metabolic pathway analysis revealed that the
majority of the metabolites mapped to carbohydrate and nucleotide metabolism show a decreasing
trend in concentration up to 81 hours post-challenge whereas an increasing trend was found in lipid
metabolites and di-, tri- and tetra-peptides up to the same time point. The increase in these peptides
coincides with an increase in larger peptides found in the previous peptidomic analysis and is likely to be
due to protease degradation of milk proteins. Components of bile acid metabolism, linked to the FXR
pathway regulating inflammation, were also increased. Metabolomic analysis of the response in milk
during mastitis provides an essential component to the full understanding of the mammary gland’s
response to infection.
1. Introduction
Bovine mastitis, which generally develops as a sequel to intra-
mammary infections, is a major infectious disease problem in
dairy cows, costing the global dairy industry h16–26 billion per
annum (www.dairy.ahdb.org.uk, accessed March 2016). How-
ever, recent advances in analytical sciences which have enabled
the ‘‘omics revolution’’ have not been fully applied to this most
important disease for the dairy industry. This paper reports
a metabolomics investigation of an experimental model of
Streptococcus uberis mastitis, adding to previous studies which
have examined the pathophysiology of the immunological
responses,1 the protein changes in the acute phase reaction
along with the omic investigation of the peptidome2 and the
system-wide quantitative proteomic analysis.3 The overview of
mastitis provided by such a systems biology approach to the
analysis of proteins, peptides and other metabolites in milk
linking to disease progression provides a unique view of the
pathological processes involved. In contrast to proteomics and
peptidomics that analyse intact proteins and peptides (the latter
consisting mostly of degradation-derived short protein fragments
(polypeptides)), metabolomics analyses low-molecular weight
metabolites of endogenous and exogenous origin. Most meta-
bolites analysed have a mass less than 1.5 kDa.4
Metabolomics applies analytical chemistry techniques such as
nuclear magnetic resonance (NMR) spectroscopy or hyphenated
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mass spectrometry combined with advanced computational
and informatics methods to analyse low molecular weight
compounds in a biological sample.5–7 It has previously been
applied to milk in relation to physiology and composition.8–12
There have also been investigations of mastitis using Gas
Chromatography-Mass Spectrometry (GC-MS) and NMR spectro-
scopy basedmetabolomics approaches. Hettinga et al., employed
two different GC-MS approaches for quantification of volatile
metabolites in milk during clinical mastitis caused by one of the
five principal causative organisms, and demonstrated the speci-
ficity of distinct volatile metabolite profiles in milk for intra-
mammary infections.13–16 Using a NMR spectroscopy approach,
Sundekilde et al., identified differentially expressed metabolites
in skimmed milk that differed between samples with low or high
somatic cell count (SCC).17 They reported increased amounts of
lactate, butyrate, isoleucine, acetate and b-hydroxybutyrate, and
decreased amounts of hippurate and fumarate in milk samples
with high SCC.
Curiously, there has been no previous report of metabolomics
profiling of milk duringmastitis using a Liquid Chromatography
Mass Spectrometry (LC-MS) approach. Compared with NMR
spectroscopy or GC-MS, LC-MS has the potential to analyse a
larger proportion of the metabolome due to its high sensitivity.7
Hence we used a LC-MS method to quantify temporal changes in
metabolite concentrations in milk during mastitis in an experi-
mental model of the disease. The aim of this part of the overall
investigation was to assess the variation in the metabolome
in bovine milk samples following progression of the experi-
mental intramammary challenge with a host-adapted strain of
Streptococcus uberis (FSL Z1-048).1 S. uberis represents an
important cause of mastitis in dairies in the UK and it has
been shown to cause severe disease which is often difficult to
control.18 The goal of the metabolomics analysis was to identify
the metabolites that demonstrated either an increase or decrease
in milk from infected udder quarters over a time course from pre-
infection to resolution. This would provide a better understand-
ing of metabolic pathways altered in mastitis, and along with the
results of the immunological, acute phase, peptidomic and
proteomic investigations provide a novel insight into the bacterial
IMI and the host response.
2. Materials and methods
Cows (n = 6) were challenged with Streptococcus uberis strain
FSL Z1-048 in a single bacteriologically negative udder quarter
per cow as previously described.1 Aliquots of milk samples
collected from six selected time points (0, 36, 42, 57, 81 &
312 hours post-challenge) of the challenge study were used to
generate untargeted metabolomics data, as was done in the
associated peptidomic2 and proteomic studies.3 The time-points
were selected on the basis of the changes in the clinical mani-
festations, bacterial load and somatic cell counts over the course
of the experimental challenge study.1 Body temperature of the
cows and bacterial concentrations in milk from challenged
quarters peaked from 24 hours (bacteria) or 30 hours (temperature)
post-challenge up to 57 hours post-challenge and had decreased
to a plateau by 81 hours post-challenge, whereby body tempera-
ture had returned to normal and bacterial concentrations in
culture positive quarters stayed constant until the end of the
study at 312 hours post-challenge. All animal experiments were
conducted at the Moredun Research Institute (Penicuik,UK) with
approval of the Institute’s Experiments and Ethical Review
Committee in accordance with the Animals (Scientific Procedures)
Act 1986.1
2.1 Untargeted metabolomic data generation
The aliquots of milk samples were stored at 20 1C at the
Moredun Research Institute, Edinburgh and were transported
frozen to Garscube campus of the University of Glasgow for
metabolomic data generation and analysis. The samples were
thawed at 4 1C and metabolites were extracted using chloroform
and methanol (1 : 3 v/v) mixture.19,20 400 ml of 1 : 3 (v/v) chloro-
form and methanol mixture was added to 100 ml of skimmed
milk sample, and vigorously extracted on a vortex mixer for two
hours at 4 1C. The mixture was centrifuged at 13000  g for
5 minutes at 4 1C, and then the supernatant was separated and
stored at80 1C until used for LC-MS analysis. A Dionex UltiMate
3000 RSLCnano (liquid chromatography) system coupled to a
Thermo Scientific Exactive Orbitrap mass spectrometer was
used for LC-MS analysis. Glass vials containing 200 ml of the
extracted analyte from the samples were loaded on the RSLC
Autosampler connected to a 4.6 150 mm SeQuant ZIC-pHILIC
(Merck KGaA, 6427 Darmstadt, Germany) column. 10 ml of the
analyte was injected in every run. Separation of the analyte was
achieved by a mobile phase composed of a two solvent system
consisting of solvent A: 20 mM ammonium acetate (pH 9) and
solvent B: acetonitrile (ACN) with a flow rate of 300 ml min1.
Chromatographic conditions for LC-MS included a gradient of
80% ACN to 5% ACN (solvent B) in 15 minutes, then held at 5%
for 3 minutes, returned to 80% in 1 minute, equilibrated for
6 minutes. The total run time was 25 minutes per sample. The
MS acquisition was performed in full scan acquisition mode on
both negative and positive polarities using ESI ionization
mode. The MS was set at 50 000 resolutions with the scan range
from 70–1400 amu. The LC-MS analysis was performed at
Glasgow Polyomics, College of Medical, Veterinary and Life
Sciences, University of Glasgow, UK.
2.2 Untargeted metabolomic data analysis
The raw LC-MS data obtained from each sample were visually
examined by generating a number of plots using MZmine
(version 2.10) software.21 To examine sample loading and peak
resolution, total ion current (TIC) chromatograms and base
peak chromatograms were generated from data obtained from
each sample. The raw LC-MS data from the quality control passed
samples were imported into the IDEOM22 software package
(version 18). Raw data was converted from the Thermo Scientific
‘RAW’ file format to an open-source ‘mzXML’ file format,
centroided and split into positive and negative polarities using
MSConvert tool.23 Chromatographic peak detection was per-
formed using XCMS24 using the centWave algorithm and saved
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in the peakML format, peak matching and annotation of
related peaks were achieved using mzMatch.R.25 Artefacts and
noise were filtered out using IDEOM software using the default
parameters. Metabolite identification was performed in IDEOM
software package by matching retention times and accurate
masses of detected peaks with either the authentic standards
(MSI confidence level 1) or the predicted retention times
and masses from a previously validated model (MSI confidence
level 2).26–28 For improved annotation of metabolites, a mixture
of 148 authentic standards were run in the LC-MS system to
predict retention times using the IDEOM software. Where there
are multiple metabolite names associated with a given mass
and retention time, the metabolite names were selected auto-
matically in the IDEOM software as the best match to the database
entries of the given mass and formula, and then reviewed
manually. In the absence of additional information, these meta-
bolite names must be considered as putatively-annotated hits.
Using the Parteks Genomics Suites (version 6.6)29 software,
principal components analysis (PCA) and hierarchical clustering
analysis (Euclidian distance and average linkage) were performed
on the combined peak intensities from positive and negative
polarities that were processed using IDEOM. To identify differen-
tially expressed metabolites, a T-test with time as factor, compar-
ing each time-point with time-point 0 hour post-challenge was
performed using the IDEOM software. In addition, one-way
analysis of variance (ANOVA) test with time as factor was
performed on the putatively identified metabolites data, and
using a threshold of an absolute fold-change more than 2 and
FDR-adjusted p-value less than 0.05, differentially expressed
metabolites lists were generated by comparing each time-point
with 0 hour time-point. Further, the list of the identified meta-
bolites were exported from IDEOM to Pathos30 and iPath31 web-
based metabolomics tools to identify the represented metabolic
pathways and to visualize the metabolic pathways in which the
metabolites are generally present.
3. Results
3.1 Quantification of metabolites
Out of the 36 samples (milk from six cows at six selected time
points), only 32 samples passed the initial quality control and
were subsequently included in the downstream analysis. The
base peak chromatograms showed overall consistency between
the replicates in each time-point (Fig. S1, ESI†). A total of 3828
different peaks were detected over all 32 samples analysed,
1027 peaks were in the positive ionisation mode while 2801 were
in the negative ionisation mode. Out of the peaks detected, after
resolving adducts and charged states, 1043 features (potential
metabolites) were deduced, and from that 740 metabolites were
identified by IDEOM (Table S1, ESI†), and then they were reviewed
to remove multiple identities, thus reducing the number to
690 putatively identified metabolites (Table S2, ESI†). Overall,
the mass of metabolites identified ranged between 69 and
888 Da. Exploratory data analysis such as hierarchical clustering
analysis and principal components analysis were performed on
the combined chromatographic peak intensities from positive
and negative polarities after removing the noisy peaks.
3.2 Hierarchical clustering analysis
To explore the dataset, a hierarchical clustering analysis (HCA)
using Euclidean distance and average linkage agglomeration
method was performed on the peak intensity data from the
3828 chromatographic peaks combined from both negative
and positive polarities. The hierarchical clustering analysis
(Fig. 1) shows three top-level clusters in the column dendro-
gram. Cluster A on the top right hand side includes milk
samples from 36 hour (shown in grey) and 42 hour (shown in
violet) post-challenge, corresponding to the early stages of the
infection and inflammation, which is characterized by bacterial
growth and cytokine release.1 It also has milk samples from
57 hour (shown in orange) and 81 hour (shown in red) post-
challenge of cow 5, which was previously identified as a late
responder based on clinical manifestations and cytokine profil-
ing,1 and 57 hour post-challenge samples from cows 1 and 4.
Cluster B, which is in the middle, includes samples exclusively
from 57 hour and 81 hour post-challenge, and corresponds
to the decreasing bacterial load.1 Cluster C is the farthest
from right, and includes all the samples from 0 hour (shown
in green) and 312 hour (shown in blue) post-challenge, which
reflects the similarity between the pre-infection and the late
resolution (mostly cleared of infection) stages. It also includes
36 hour samples from cow 5 and 1, and 42-hour post-challenge
sample from cow 5.
Fig. 1 Hierarchical clustering analysis of the detected peaks showing
column dendrograms. Hierarchical clustering analysis was performed on
the 3828 detected peak intensities using Euclidean distance and average
linkage agglomeration methods. The column dendrograms show the
clustering of the milk samples. The column dendrograms also show three
top-level clusters, identified by letters (A = early to peak infection based on
bacterial numbers; B = post peak infection; C = pre-challenge and
resolution stage), time points by colours (see inset), and individual cows
by numbers. The scale bar shows the intensities in log2 scale. Please note
that there are only 32 samples as data from 4 samples were not included
after initial quality analysis at raw data level.
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3.3 Principal component analysis
To further explore the dataset, a principal component analysis (PCA)
was performed on the combined peak intensities (3828 chromato-
graphic peaks) data. The PCA plot (Fig. 2) shows the plotting of
samples using principal component 1 (PC1) and principal compo-
nent 2 (PC2). The clustering pattern of samples in the PCA is similar
to the HCA, and reflects the time course. Overall, the clusters are
separated on the PC1, which has captured 40.4% of variance in
the dataset. The samples at time points 0 hour post-challenge and
312 hour post-challenge formed distinctive clusters, and are shown
in Fig. 2 indicated by green and blue respectively, are closer
compared to the samples from other time points. The clusters
formed by time-points 0 hour and 81 hour post-challenge
samples has the greatest distance on PC1, and the clusters
formed by samples from other time-points are located between
these two extremes. As in the HCA, samples from cow 5 are seen
as outliers showing slow response evidenced by the clinical,
bacteriological and biochemical parameters.1
3.4 Differential expression analysis
To identify the metabolites that were differentially expressed
over the time course, particularly between pre- and post-
challenge, a one-way ANOVA test was performed with time as
factor. The lists of differentially expressed metabolites (Table S2,
ESI†) were created for each comparison using a threshold of an
absolute fold-change more than 2 and FDR-adjusted p-value less
than 0.05. Compared with the pre-challenge time-point, there
were 222 (156 up & 66 down), 310 (193 up & 117 down), 476
(277 up & 199 down), 490 (303 up & 187 down) and 133 (104 up &
29 down) putative metabolites differentially expressed respec-
tively at 36 hours, 42 hours, 57 hours, 81 hours and 312 hours
post-challenge.
3.5 Perturbations in the metabolic pathways
Most of the annotated metabolites were mapped to KEGG refer-
ence pathways,32 and the results showed alterations to a number
of mapped pathways including amino acid metabolism such as
alanine, aspartate and glutamate metabolism, nucleotide meta-
bolism such as purine and pyrimidine metabolism, carbohydrate
metabolism such as ascorbate and aldarate metabolism, lipid
metabolism such as Eicosanoids pathway. There were significant
changes in the di-, tri- and tetra-peptides concentrations in milk
over the time course of the experimental challenge. Heat map
(Fig. 3) plotting the fold-changes of metabolite concentrations
mapped to amino acid metabolism, carbohydrate metabolism,
lipid metabolism, nucleotide metabolism and di-, tri- and tetra-
peptides shows increasing trend in lipid metabolism and di-, tri-
and tetra-peptides up to 81 hours post-challenge. Conversely, the
majority of the metabolites mapped to carbohydrate metabolism
and nucleotide metabolism show a decreasing trend in concen-
tration up to 81 hours post-challenge. The observations were
further corroborated by the results from Pathos web-based tool
that showed the intensity of changes in KEGGmetabolic pathways
at each post-challenge time-point compared to the pre-challenge
metabolite levels (Tables S3–S7, ESI†). In addition, themapping of
metabolites on the KEGG metabolic, regulatory and biosynthesis
pathways were visually examined using iPath web-based tool
(Fig. S2–S4, ESI†).
4. Discussion
This study was an untargeted global metabolomics investigation
of skimmed milk, carried out to characterise the metabolite
profile of skimmed milk and its changes with time during the
Fig. 2 Principal component analysis of the metabolome after intra-
mammary challenge with Streptococcus uberis. The PCA was based on
the intensities from 3828 detected peaks and the plot was generated using
the Partek Genomic suite. The data points refer to milk samples obtained
from 6 cows at 6 time points post challenge (PC). Cows are identified by
number and time points by colour, with hours PC shown in the legend.
Please note that there are only 32 samples as data from 4 samples were
not included after initial quality analysis at raw data level.
Fig. 3 Heat map showing the fold-changes of putative metabolites mapped
to KEGG metabolic pathways. Fold-change of putative metabolites in each
contrast (each time-point compared with 0 hour post-challenge) was com-
puted from the one-way ANOVA test. The metabolites were mapped to
KEGG metabolic pathways using IDEOM software, and then the heatmap
was plotted using the Partek Genomic suite.
Paper Molecular BioSystems
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
Ju
ly
 2
01
6.
 D
ow
nl
oa
de
d 
on
 5
/1
8/
20
20
 4
:1
5:
52
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
2766 | Mol. BioSyst., 2016, 12, 2762--2769 This journal is©The Royal Society of Chemistry 2016
course of an intramammary challenge with a host-adapted
strain of S. uberis, an important environmental pathogen of
mastitis. Of particular importance is the ability to relate the
findings of this metabolomic investigation with the pathophysio-
logical, immunological, proteomic and peptidomic changes
described in the previous and accompanying reports.1 All data
obtained from post infection time-points were statistically com-
pared with values at 0 hours. It is expected that metabolomic
investigation of milk would yield a high number of metabolites17
and in this analysis over 3000 chromatographic peaks were
detected, of which 690 were putatively annotated with a definitive
metabolite. The number of compounds identified in this study is
by far the largest in any previous metabolomics study using
bovine milk.8,15,33 This may be due to the methodology used,
LC-MS, which is known to be of higher sensitivity than other
metabolomics techniques such as H-NMR spectroscopy, although
having its own disadvantages such as lower reproducibility and
difficulty in identifying spectral features.7 While many methods
exist for extraction of metabolites, we used chloroform and
methanol (1 : 3 v/v) mixture, based on its complementarity with
the LC-MS system in our in-house experience.28 This method is
based on the original Folch method34 and is known to be
effective for the extraction of a broad range of metabolites
including lipids.19,20,35
A notable finding of this study is the change in metabolite
composition of bovine milk over the course of mastitis caused
by the host-adapted strain of Streptococcus uberis. The time-
points used in the omics analyses include a pre-infection
(0 hours post-challenge), peak bacterial load and peak body
temperature of cows (36 hours post-challenge), rapidly declin-
ing bacterial load and body temperature of cows (42, 57 and
81 hours post-challenge) and spontaneous clearing of infection
with one cow being an exception (312 hours post-challenge).
The number of differentially expressed metabolites increased
over the course of infection, and peaked at 81 hours post-
challenge. The number of modulated metabolites, and the
amplitude of change, peaked at 81 hours post-challenge. These
patterns were similar to those found by peptidomic analysis
and in the proteomic analysis, although in the latter a number
of proteins peaked at 57 hours post challenge. However,
principal component analysis and hierarchical clustering
analysis of both the metabolomic and proteomics datasets
showed comparable patterns in that the samples from 57 hours
and 81 hours are divergent from 0, 36 and 42 hours post-
challenge. However, these patterns are contradictory to the
clinical and bacteriological profiles where the largest change
occurs at 36 hours post-challenge.
We observed increasing concentrations of bile acids such
as taurochenodeoxycholic acid (C26H45NO6S), taurocholic acid
(C26H45NO7S), glycocholate (C26H43NO6), glycodeoxycholate
(C26H43NO5) and cholate (C24H40O5) over the time course until
81 hours post-challenge (Fig. 4). The bile acids are produced by
liver and are thought to have antimicrobial activity through
their detergent property in the intestinal tract.36,37 Their
immunomodulatory roles are thought to be mediated through
the farnesoid X receptor (FXR) pathway,38 which was one of the
pathways enriched in the proteomics analysis.3 As there is
evidence in both metabolomic and proteomics analysis, the
involvement of the FXR pathway in bovine mastitis could be
studied in detail. In addition to FXR, 3 other nuclear receptors
involved in immunomodulatory activities (pregnane X receptor
(PXR), constitutive androstane receptor (CAR) and vitamin D
receptor (VDR)) are known to be activated by specific bile
acids.39,40 Increased intracellular bile acids concentration results
in the transcriptional activation of these nuclear receptors.
Activated FXR ligands exert anti-inflammatory activity through
their interaction with other transcription factors including acti-
vator protein 1 and nuclear factor-kB (NF-kB).41 Similarly, PXR
exhibits anti-inflammatory role by inhibiting the expression of
NF-kB target genes, and the production of interleukins and
chemokines.40,42 Likewise, vitamin D3 plays an inhibitory role
in the production of pro-inflammatory cytokines.40,43 Further-
more, immunomodulatory role of bile acids can be linked to
TGR5, a bile acid activated G-protein-coupled receptor which
increases the production of cAMP in innate immune cells
leading to downregulation of inflammatory cytokines such as
tumour necrosis factor alpha (TNF-a), interleukin-1 beta (IL-1b),
interleukin-6 (IL-6) and interleukin-8 (IL-8).44,45 Interestingly,
profiles of pro-inflammatory cytokines in milk (Fig. 8, Tassi
et al.1) over the time course in our study were comparable with
the concentrations of bile acids in milk quantified in this
analysis. Peak concentrations of TNF-a, IL-1b, IL-6 and IL-8 in
milk were found between 36 and 48 hours post-challenge,1 and
as the concentrations of bile acids increased, the concentration
of pro-inflammatory cytokines decreased. Furthermore, peroxi-
some proliferator-activated receptors (PPAR) signalling, retinoid
X receptor (RXR) activation and liver X receptor (LXR) activation
signalling pathways, which are known to be associated with bile
acids metabolism and signalling39 were found to be enriched in
the proteomic analysis.3
We found hippurate (C9H9NO3) concentration decreasing over
time, with its lowest level reaching at 57 hours post-challenge.
Similarly, lactose (C12H22O11) concentration decreased over
time,46,47 and could not be detected at 81 hours post-challenge.
Fig. 4 Changes in the concentration of bile acids and lactate in milk after
intramammary challenge with Streptococcus uberis. Fold-changes for
each metabolite at 36, 42, 57, 81 and 312 hours post-challenge compared
with 0 hours post-challenge were analysed using a one-way ANOVA. The
time course profile of fold-changes shows the increasing concentration of
bile acids and lactate over the course of the infection, reaching highest
levels at 81 hours post-challenge, and then dropping down to pre-
infection levels at 312 hours. This figure shows fold-change in log10 scale.
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The decreasing trend of lactose concentration in milk is sup-
ported by the proteomics analysis in which alpha-lactalbumin,
a regulatory subunit of lactose synthase involved in the lactose
synthesis, was down-regulated over the time course.3 A previous
study showed decreased concentrations of hippurate and lactose
in milk associated with the elevated SCC,17 and suggested that
the decreased concentration of lactose could be to maintain
osmotic pressure of milk to compensate the flow of blood
constituents into milk. We also observed increased concentra-
tions of lactate (C3H6O3) over the time course with the highest
concentration at 42 hours post-challenge. Lactate is an end
product of bacterial metabolism15,17 and correlates with the high
bacterial load in milk, but could also be due to an increase in
anaerobic metabolism in the host. Using a NMR spectroscopy
based metabolomics approach, Sundekilde et al., reported
increased concentration of isoleucine in milk with the elevated
SCC.17 In our study we found up-regulation of leucine (C6H13NO2)
over the time course, with its highest concentration at 81 hours
post-challenge. Identification of isomers such as leucine and
isoleucine is a limitation in the LC-MS based methodology
compared with the NMR spectroscopy, and this might well be
isoleucine instead of leucine in our case.
Mapping the metabolites to KEGG pathways, we identified
perturbations in amino acid metabolism, carbohydrate meta-
bolism, lipid metabolism, nucleotide metabolism and meta-
bolism of di-, tri- and tetra-peptides. This is further supported
by our peptidomic study.2 The increasing trend in the meta-
bolism of di-, tri- and tetra-peptides over the time course post-
challenge (Fig. 3) could be attributed to the bacterial lysis
of proteins. Most of these compounds were not detected at
0 hours, but their concentration increased at 36, 42, 57 and
81 hours post-challenge, and then decreased (or were not
detected) at 312 hours post-challenge, by which time the infection
was resolved. It is possible that the increase in small molecular
weight peptides is due to the activities of plasma proteases such as
plasmin, leukocyte associated proteases and cathepsins, as well as
bacterial proteases.48,49 There is a decreasing trend in carbohy-
drate metabolism over the time course, and this could be due to
the utilization of carbohydrates by bacteria or their production
may be inhibited as part of host response to deprive the bacteria
of readily available energy substrates. We also observed down-
regulation of lipid metabolism over the time course with the
increase of inflammation. The sample extraction method and
the chromatographic separation might significantly affect the
discovery of the lipid compounds, and a specialised lipidomic
method should be used to study the lipid compounds. With
this limitation, we found that most lipids were eluted in the
first 5 minutes of the LC-MS run. There was a mixed trend in
the Eicosanoids pathway, which is an important metabolic
pathway for arachidonic acid metabolism. 18-Acetoxy-PGF2alpha-
11-acetate (C24H38O8), a prostaglandin in the Eicosanoids pathway
was not detected at 0 hours and 312 hours post-challenge, but
present in the rest of the time-points, while 2,3-dinor-8-iso-
PGF2alpha (C18H30O5) another compound in the Eicosanoids
pathway and a product of prostaglandin metabolism showed
increasing trend, peaking at 81 hours post-challenge. However,
PGF2-alpha methyl ether (C21H38O4) was significantly down-
regulated over the course with its lowest level at 81 hours post-
challenge (fold-change =4.3375, FDR-adjusted p-value = 0.0421).
Eicosanoids, particularly PGF2-alpha, are important mediators in
the acute inflammatory process, and prostaglandins are known to
be up-regulated in milk during mastitis.50
Fig. 5 The relative responses of analytes following experimental induced S. uberis mastitis combining metabolomic results with data from Tassi et al.,1
Thomas et al.,2 and Mudaliar et al.3 The shading represents strength of the response relative to the peak response. Responses were increases compared
to day 0 levels except for casein levels (indicated by *), which decreased after challenge. cfu ml1 – bacteria count in colony forming units per ml;1
SCC – somatic cell count;1 IL – interleukin;1 TNF – tumor necrosis factor;1 LF – lactoferrin;2 Hp (ELISA) – haptoglobin as detected by enzyme linked
immunosorbent assay;2 mSAA3 – milk derived serum amyloid A;2 CRP – C-reactive protein;2 IMI77 – peptidomic profile based on 77 peptides;2
Hp (LC-MS/MS) – haptoglobin as detected by liquid chromatography and tandem mass spectrometry;3 PepGly – peptidoglycan recognition protein 1;3
Cath5 – cathelicidin-5;3 Annex1 – Annexin A1;3 PhenylPro – phenylpropanoate.
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The integrated omic analyses that have been undertaken on
themilk samples taken over 312 hours following IMI with S. uberis
and linking to the clinical and pathophysiological analyses on the
same samples provides a unique view on the multifaceted host
responses to the bacterial infection. This system-based approach
has been most revealing in providing an insight into the integra-
tion of the responses mounted by the mammary gland in the face
of bacterial invasion. A key finding has been that while the
bacterial count reaches a peak within 36–42 hours post challenge,
many of the host responses do not reach a peak until a 57 or
81 hours post challenge (Fig. 5). As this pattern is present in all
three omics analyses (peptidomics, proteomics and meta-
bolomics), it provides opportunities for further research. The
results here would have benefited from further time point analysis
in the resolution phase of the infection between 81 and 312 hours
post-challenge. However, it is clear that by using multiple omics
technologies, the connectivity of bacterial invasion, cytokine
mediation leading to protein, peptide and metabolite modifica-
tions during mastitis can be characterised. Among omic technol-
ogies there are a variety of approaches to be taken. In proteomics,
2 dimension electrophoresis, difference gel electrophoresis as well
as the CE-MS and LC-MS/MS approach used in this series of
experiments2,3 while alternatives such as nuclear magnetic
resonance could also be used for metabolomics. The selected
approaches were used as being the most suitable for this
sample set in order to demonstrate the value of integrated
omics in a systems based investigation of bovine mastitis. This
polyomic approach should be applied to assessment of com-
parative responses to other mastitis causing pathogens to
determine how the responses are altered due to bacterial
species with the potential of a differential biomarker panel of
proteins, peptides and metabolites being developed. The data
generated by the LC-MS metabolomics analysis is available in
the ESI† (Table S1) and others working in the field may identify
further responses to mastitis in pathways not highlighted here.
Modification to the multi-analytes covered by these investiga-
tions in response to mastitis therapy, whether by pharmaco-
logical or biologic agent or by vaccination would be a further
potential application of the integrated approach to the study of
mastitomics.
5. Conclusions
The present study used an LC-MS-based untargeted metabolomic
approach to profile the changes in metabolite concentration in
milk during the course of the experimental S. uberis mastitis
infection. We identified changes in several hundred metabolites
over the course of the infection. Significantly, we found changes
in the concentration of bile acids in milk and compared them
with the concentration of cytokines suggesting anti-inflammatory
role of the bile acid receptor pathway. Involvement of bile acids in
the resolution of mastitis through activation of nuclear receptors
could potentially a novel discovery in this study. We compared
the observations in the current study with the proteomics
and peptidomics studies associated with the same sample set.
This system-wide analysis of peptides, proteins and other
metabolites in milk and the changes in the clinical manifesta-
tions and bacterial load provided a unique view of the patho-
logical processes in bovine mastitis. Particularly, we found
links to enrichment of FXR pathway in the proteomics data
and the increased concentration of bile acids in the metabo-
lomic data. Similarly, the down-regulation of lactose over the
course of mastitis could be associated with the down-regulation
of alpha-lactalbumin. We have also demonstrated high correla-
tion in the dynamics of peptides, proteins and metabolites over
the course of the experimental infection.
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